Cargando…
Amyloid beta soluble forms and plasminogen activation system in Alzheimer’s disease: Consequences on extracellular maturation of brain‐derived neurotrophic factor and therapeutic implications
Soluble oligomeric forms of amyloid beta (Aβ) play an important role in causing the cognitive deficits in Alzheimer’s disease (AD) by targeting and disrupting synaptic pathways. Thus, the present research is directed toward identifying the neuronal pathways targeted by soluble forms and, accordingly...
Autores principales: | Angelucci, Francesco, Čechová, Kateřina, Průša, Richard, Hort, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488905/ https://www.ncbi.nlm.nih.gov/pubmed/30403004 http://dx.doi.org/10.1111/cns.13082 |
Ejemplares similares
-
Antibiotics, gut microbiota, and Alzheimer’s disease
por: Angelucci, Francesco, et al.
Publicado: (2019) -
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
por: Angelucci, Francesco, et al.
Publicado: (2019) -
Effect of a Vegan Diet on Alzheimer’s Disease
por: Katonova, Alzbeta, et al.
Publicado: (2022) -
Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s
Disease and Correlates
with Disease Severity
por: Angelucci, Francesco, et al.
Publicado: (2023) -
Administration of pre/probiotics with conventional drug treatment in Alzheimer’s disease
por: Hort, Jakub, et al.
Publicado: (2019)